Reference material, not a guide. We index what published research literature says about each compound — mechanism of action, structure, study history, stability characteristics. No outcome claims, no dosing for humans, no protocols.
Published preclinical and translational literature on Retatrutide (LY3437943) and adjacent triple-agonist sequences. Receptor pharmacology, in-vitro characterization, and the long-acting backbone modifications described across the source literature.
Background reading on the GHRH-analogue family (sermorelin, tesamorelin, CJC-1295 with and without DAC) and the small-peptide ghrelin mimetics (Ipamorelin, hexarelin, GHRP-2/6). Sequences, half-life modifications, receptor selectivity, and the literature on their use as research probes.
Annotated digest of in-vitro and animal-model literature on BPC-157 (the 15-amino-acid gastric-juice-derived fragment) and TB-500 (Ac-LKKTETQ, the actin-binding fragment of thymosin beta-4). Sequence-verification methods, cellular-mechanism studies, and stability characterization findings reported in peer-reviewed sources.
Literature on Semax (Met-Glu-His-Phe-Pro-Gly-Pro), its derivation from the natural ACTH(4–10) sequence, structural modifications described in published synthesis methodology, and preclinical investigations of melanocortin-receptor binding and BDNF expression reported across the research record.
Background on the tuftsin tetrapeptide (Thr-Lys-Pro-Arg) and the elongated synthetic analogue Selank (TKPRPGP). Animal-model literature, GABAergic-pathway characterizations, and the proteolytic-stability modifications described in published synthesis work.
Notes on the nonapeptide DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu), its 1977 isolation from rabbit cerebral venous blood by the Schoenenberger group, chemical synthesis methodology, and the in-vitro and animal-model studies reported in the research literature.
Literature on the 16-amino-acid MOTS-C, encoded within the 12S rRNA mitochondrial open reading frame. Published metabolic and biochemical characterizations, AMPK-pathway notes, and synthesis methodology references.
Reference reading on nicotinamide adenine dinucleotide and its precursors (NMN, NR), the salvage and de novo biosynthesis pathways, and published in-vitro and animal-model investigations of NAD+ metabolism, sirtuin activation, and age-related decline.